Funder: Alliance for Cancer Gene Therapy
Due Dates: May 16, 2025 (Letter of Intent/Abstract) | August 22, 2025 (Full Application)
Funding Amounts: Up to $500,000 total over 2–3 years (max 10% indirect costs)
Summary: Supports innovative cell and gene therapy research to improve breast cancer treatment and outcomes.
Key Information: Research must be conducted at academic centers in the US or Canada; open to tenure-track/tenured faculty and select biotech partnerships.